Patent ID: 8309571

Claim:
A compound of Formula (I): or an enantiomer, diastereomer or pharmaceutically-acceptable salt thereof, wherein: L is —C═; M is —N—; Q is a bond; R 1 is independently selected at each occurence from halo and haloalkyl; R 2 is —[C(O)] 2 NR 7 R 8 , wherein each of R 7 and R 8 is independently an optionally substituted C 1-6 alkyl, and further wherein R 7 and R 8 can be taken together with the atoms to which they are attached to form an optionally substituted 5-6 member ring; R 3 is selected from hydrogen and alkyl; R 4 is selected from the group consisting of hydrogen, CO 2 R 11 , and CONR 11 R 12 , wherein each of R 11 and R 12 are independently selected from the group consisting of H, C1-C6 straight or branched chain alkyl, C1-C4 straight or branched chain alkyl amino, C1-C4 straight or branched chain dialkyl amino, C1-C4 straight or branched chain alkyl with an OH group, and C4-C10 heterocyclo with 1-3 members selected from the group consisting of N, S and O; provided there are no O—O or S—S bonds in R 3 and R 4 and any of the heterocyclo groups can be optionally substituted with a member of the group consisting of C1-C4 alkyl, optionally substituted amino, and alkyl amino; ring A is selected from phenyl, indole, indazole, benzimidazole, pyrrolo[2,3-b]pyridine, and 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole; B is —(CR 5 R 6 ) q — wherein R 5 and R 6 are each independently selected from the group consisting of hydrogen and optionally substituted alkyl; m is 0-2, wherein when m=2 then (a) the 2 R 1 groups can be separate substituents or (b) the 2 R 1 groups, together with the carbons to which they are attached can form a fused ring, wherein (a) and (b) can each optionally be substituted with a member selected from the group consisting of cycloalkyl, benzyl, benzoyl, aryl, heterocyclo and heteroaryl; q is 0; and n is 0-3.